Glaukos Corp. (GKOS)

124.79 +3.17 (+2.61%) USD  |  NYSE  |  Apr 17, 16:00
124.74 -0.05 (-0.04%) Pre-Market: 20:00
More

Glaukos SG&A Expense (Quarterly) : 94.70M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for GKOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 1.834B
Intuitive Surgical, Inc. 687.10M
ResMed, Inc. 278.40M
Globus Medical, Inc. 318.48M
Plus Therapeutics, Inc. 4.168M